| 1 | Study | 2.05% | |
| 2 | Cancer | 1.25% | |
| 3 | Patients | 1.25% | |
| 4 | New | 1.03% | |
| 5 | Report | 0.8% | |
| 6 | Case | 0.68% | |
| 7 | ASCO | 0.68% | |
| 8 | AI | 0.68% | |
| 9 | Health | 0.68% | |
| 10 | Therapy | 0.68% | |
| 11 | Found | 0.57% | |
| 12 | Linked | 0.57% | |
| 13 | Disease | 0.46% | |
| 14 | Phase | 0.46% | |
| 15 | Cell | 0.46% | |
| 16 | Blood | 0.46% | |
| 17 | Brain | 0.46% | |
| 18 | Prostate | 0.46% | |
| 19 | MRI | 0.46% | |
| 20 | Early | 0.34% | |
| 21 | Breast | 0.34% | |
| 22 | Exercise | 0.34% | |
| 23 | Surgery | 0.34% | |
| 24 | Strategies | 0.34% | |
| 25 | Medical | 0.34% | |
| 26 | Treatment | 0.34% | |
| 27 | Survival | 0.34% | |
| 28 | China | 0.34% | |
| 29 | Effects | 0.34% | |
| 30 | Colon | 0.34% | |
| 31 | Shows | 0.34% | |
| 32 | Receptor | 0.34% | |
| 33 | Risk | 0.34% | |
| 34 | Against | 0.34% | |
| 35 | Human | 0.34% | |
| 36 | Use | 0.34% | |
| 37 | Could | 0.34% | |
| 38 | Primary | 0.34% | |
| 39 | Cells | 0.34% | |
| 40 | First | 0.34% | |
| 41 | Announces | 0.34% | |
| 42 | Metabolic | 0.34% | |
| 43 | Identify | 0.23% | |
| 44 | Growth | 0.23% | |
| 45 | Trials | 0.23% | |
| 46 | Chemotherapy | 0.23% | |
| 47 | Clinical | 0.23% | |
| 48 | Obesity | 0.23% | |
| 49 | Neoadjuvant | 0.23% | |
| 50 | Fight | 0.23% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
Halo Biosciences Announces Thorax Publication of Phase 2a SATURN Study Results in PH-ILD
Business Wire
2025-06-04 21:00:00
Gyre Therapeutics' Hydronidone Meets Primary Endpoint in Phase 3 Hepatitis B Trial
Contagion Live
2025-06-04 15:03:00
Managed Healthcare Executive
2025-06-04 07:49:53